Recently added

SEB-induced IL-13 production in CLA+ memory T cells defines Th2 high and Th2 low responders in atopic dermatitis

Jesús Gil, Carmen de; García-Jiménez, Irene; Sans De San Nicolàs, Lídia; Figueras, Ignasi; Guilabert, Antonio; Bonfill Ortí, Montserrat (Wiley, 2022-06-30)

Real‑life analysis on safety and efcacy of asciminib for ponatinib pretreated patients with chronic myeloid leukemia

Luna, Alejandro; Boqué-Genovard, Concepción; Giraldo, Pilar; Ruiz Nuño, C.; Cortes, Montse; Pérez-Lamas, Lucía; Xicoy, Blanca (Springer, 2022-10)

Comorbid autoimmune diseases and burden of diabetes-related complications in patients with type 1 diabetes from a Mediterranean area

Navas, Elena; Cos Claramunt, Francesc Xavier; Mata-Cases, Manel; Gimenez-Perez, Gabriel; Vlacho, Bogdan; Real, Jordi (Elsevier, 2022-09)

Guidance on brolucizumab management recommendations

Fonollosa, Alex; Gallego-Pinazo, Roberto; Sararols, Laura; Adán, Alfredo; López Gálvez, María Isabel; Figueroa, Marta (Elsevier, 2022-07-23)

Shorter Time to Discontinuation Due to Treatment Failure in People Living with HIV Switched to Dolutegravir Plus Either Rilpivirine or Lamivudine Compared with Integrase Inhibitor-Based Triple Therapy in a Large Spanish Cohort

Diaz-Cuervo, Helena; Aragão, F; Castaño, Manuel; Romero, Alberto; Roca, Bernardino; Deig, Elisabeth; Curran Fàbregas, Adria; Teira, Ramon (Springer, 2022-04-11)

Scientia. Department of Health Digital Information Depot

Hospital General de Granollers - HG: Recent submissions

SEB-induced IL-13 production in CLA+ memory T cells defines Th2 high and Th2 low responders in atopic dermatitis

Real‑life analysis on safety and efcacy of asciminib for ponatinib pretreated patients with chronic myeloid leukemia

Comorbid autoimmune diseases and burden of diabetes-related complications in patients with type 1 diabetes from a Mediterranean area

Guidance on brolucizumab management recommendations

Shorter Time to Discontinuation Due to Treatment Failure in People Living with HIV Switched to Dolutegravir Plus Either Rilpivirine or Lamivudine Compared with Integrase Inhibitor-Based Triple Therapy in a Large Spanish Cohort

Scientia. Department of Health Digital Information Depot

Hospital General de Granollers - HG: Recent submissions

SEB-induced IL-13 production in CLA+ memory T cells defines Th2 high and Th2 low responders in atopic dermatitis ﻿

Real‑life analysis on safety and efcacy of asciminib for ponatinib pretreated patients with chronic myeloid leukemia ﻿

Comorbid autoimmune diseases and burden of diabetes-related complications in patients with type 1 diabetes from a Mediterranean area ﻿

Guidance on brolucizumab management recommendations ﻿

Shorter Time to Discontinuation Due to Treatment Failure in People Living with HIV Switched to Dolutegravir Plus Either Rilpivirine or Lamivudine Compared with Integrase Inhibitor-Based Triple Therapy in a Large Spanish Cohort ﻿

SEB-induced IL-13 production in CLA+ memory T cells defines Th2 high and Th2 low responders in atopic dermatitis

Real‑life analysis on safety and efcacy of asciminib for ponatinib pretreated patients with chronic myeloid leukemia

Comorbid autoimmune diseases and burden of diabetes-related complications in patients with type 1 diabetes from a Mediterranean area

Guidance on brolucizumab management recommendations

Shorter Time to Discontinuation Due to Treatment Failure in People Living with HIV Switched to Dolutegravir Plus Either Rilpivirine or Lamivudine Compared with Integrase Inhibitor-Based Triple Therapy in a Large Spanish Cohort